Literature DB >> 11384638

A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.

R Marci1, A Senn, S Dessole, A Chanson, E Loumaye, P De Grandi, M Germond.   

Abstract

OBJECTIVE: To study the benefits of a low-dose stimulation (LDS) protocol with purified urinary follicle-stimulating hormone in patients with polycystic ovaries who have presented previously with a very high ovarian response to a standard hMG stimulation.
DESIGN: Cohort study.
SETTING: Fertility center in a university hospital. PATIENT(S): Sixty-one patients involved in an IVF/ICSI program from January 1995 to December 1996. INTERVENTION(S): The patients were first stimulated with a standard protocol using hMG and presented with a very high ovarian response. These patients were then stimulated a second time using a low-dose protocol. Cryopreserved embryos were transferred in later artificial or natural cycles until to December 1999. MAIN OUTCOME MEASURE(S): Number of gonadotropin ampules; estradiol level on the day of ovulation induction; follicles, oocytes, and cryopreserved zygotes; fertilization, implantation, and pregnancy rates; and number of ovarian hyperstimulation syndromes (OHSS). RESULT(S): The number of ampules used, the estradiol level reached, and the number of oocytes obtained were significantly lower under the LDS than the standard protocol. High implantation (21.8%) and clinical pregnancy (38.4%) rates were obtained after LDS. The cumulated deliveries per cycle started and per patient were, respectively, 41.6% and 52.5%. Five patients suffered OHSS with the standard protocol, and none with the LDS. CONCLUSION(S): The LDS protocol offers a safe and efficient treatment for patients who present with echographic polycystic ovaries and are at risk of an excessive ovarian response to standard IVF stimulation protocols.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384638     DOI: 10.1016/s0015-0282(01)01788-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Intraovarian arterial blood flow resistance in oligomenorrheal infertile women.

Authors:  Koji Nakagawa; Yuji Takahashi; Megumu Ito; Takashi Horikawa; Shirei Ohgi; Minoru Irahara; Hidekazu Saito
Journal:  J Assist Reprod Genet       Date:  2006-05-12       Impact factor: 3.412

2.  Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Authors:  Yu-Hung Lin; Kok-Min Seow; Bih-Chwen Hsieh; Lee-Wen Huang; Heng-Ju Chen; Shih-Chia Huang; Chih-Yu Chen; Pei-Hsin Chen; Jiann-Loung Hwang; Chi-Ruey Tzeng
Journal:  J Assist Reprod Genet       Date:  2007-07-17       Impact factor: 3.412

3.  Patients with polycystic ovary syndrome have successful embryo arrest.

Authors:  Baoli Yin; Haoying Hao; Duo Wei; Xiaobing Song; Juanke Xie; Cuilian Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.

Authors:  L Rinaldi; F Lisi; H Selman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

5.  Studies on the effects of initial injection doses of follicle stimulating hormone on the pregnancy and the ovarian hyperstimulation syndrome incidence in polycystic ovarian syndrome patients.

Authors:  Yasuhiko Nakamura; Akihisa Takasaki; Norihiro Sugino; Hiroshi Tamura; Shuji Takiguchi; Hisako Takayama; Ayako Harada; Hiroshi Kato
Journal:  Reprod Med Biol       Date:  2003-04-30

6.  The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM.

Authors:  Carolina Ortega-Hrepich; Nikolaos P Polyzos; Ellen Anckaert; Luis Guzman; Herman Tournaye; Johan Smitz; Michel De Vos
Journal:  Reprod Biol Endocrinol       Date:  2014-02-24       Impact factor: 5.211

Review 7.  Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review.

Authors:  Enrique Reyes-Muñoz; Thozhukat Sathyapalan; Paola Rossetti; Mohsin Shah; Min Long; Massimo Buscema; Gaetano Valenti; Valentina Lucia La Rosa; Stefano Cianci; Salvatore Giovanni Vitale
Journal:  Adv Ther       Date:  2018-10-11       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.